Involvement of nitric oxide in the mitochondrial action of efavirenz: A differential effect on neurons and glial cells

36Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The anti-human immunodeficiency virus (HIV) drug efavirenz (EFV) alters mitochondrial function in cultured neurons and glial cells. Nitric oxide (NO) is a mediator of mitochondrial dysfunction associated with HIV central nervous system symptoms. We show that EFV promotes inducible nitric oxide synthase (iNOS) expression in cultured glial cells and generated NO undermines their mitochondrial function, as inhibition of NOS partially reverses this effect. EFV inhibits mitochondrial Complex I in both neurons and glia; however, when the latter cells are treated for longer periods, other mitochondrial complexes are also affected in accordance with the increased NO production. These findings shed light on the mechanisms responsible for the frequent EFV-associated neurotoxicity.

Cite

CITATION STYLE

APA

Apostolova, N., Funes, H. A., Blas-Garcia, A., Alegre, F., Polo, M., & Esplugues, J. V. (2015). Involvement of nitric oxide in the mitochondrial action of efavirenz: A differential effect on neurons and glial cells. Journal of Infectious Diseases, 211(12), 1953–1958. https://doi.org/10.1093/infdis/jiu825

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free